Information  X 
Enter a valid email address

EPIC/TIDM matching '0RDD'

Date
Time Source
Company
Announcement
01 Jul 2020 7:35 am GNW Factsheet Curetis (0RDD) Curetis N.V. in liquidatie informs on publication of audited FY2019 financial results and annual report
30 Apr 2020 6:59 am GNW Factsheet Curetis (0RDD) Curetis N.V. in liquidatie informs on delay of publication of audited FY2019 financial results and annual report
20 Apr 2020 6:59 am GNW Factsheet Curetis (0RDD) Curetis N.V. in liquidatie to announce liquidation distribution in advance and last trading day
01 Apr 2020 9:07 pm GNW Factsheet Curetis (0RDD) Curetis and OpGen Close Business Combination
25 Mar 2020 6:59 am GNW Factsheet Curetis (0RDD) Curetis N.V. Informs on OpGen’s Fourth Quarter and Full Year 2019 Financial Results and Business Update
16 Mar 2020 7:01 am GNW Factsheet Curetis (0RDD) Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe
10 Mar 2020 3:15 pm GNW Factsheet Curetis (0RDD) Curetis N.V. Updates on OpGen, Inc. Special Shareholders’ Meeting Held on March 10, 2020
  1:13 pm GNW Factsheet Curetis (0RDD) Curetis N.V. Reports Results of the Extraordinary General Meeting Held on March 10, 2020
20 Feb 2020 6:58 am GNW Factsheet Curetis (0RDD) Curetis Announces Preliminary, Unaudited 2019 Condensed Combined Key Financials and Provides Business Update
06 Feb 2020 6:59 am GNW Factsheet Curetis (0RDD) Curetis and Quaphaco Enter into Unyvero Distribution Partnership for Vietnam
30 Jan 2020 6:56 am GNW Factsheet Curetis (0RDD) Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe
27 Jan 2020 6:53 am GNW Factsheet Curetis (0RDD) Curetis to Hold Extraordinary General Meeting on March 10, 2020
23 Jan 2020 8:50 am GNW Factsheet Curetis (0RDD) Curetis To Attend Key Conferences in the First Half of 2020
14 Jan 2020 6:58 am GNW Factsheet Curetis (0RDD) Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.
20 Dec 2019 10:32 pm GNW Factsheet Curetis (0RDD) Curetis Receives U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens
10 Dec 2019 6:58 am GNW Factsheet Curetis (0RDD) Ares Genetics, a Curetis Group Company, Joins NVIDIA Inception and AWS Activate Programs
25 Nov 2019 9:02 am GNW Factsheet Curetis (0RDD) Curetis Group Company Ares Genetics Wins MERCUR Innovation Prize
  7:00 am GNW Factsheet Curetis (0RDD) Curetis Expects Near-Term U.S. FDA Decision on 510(k) Clearance of Unyvero LRT for BAL Specimens
  6:03 am GNW Factsheet Curetis (0RDD) Curetis Publishes Third Quarter and 9-Month Business and Financial Update
14 Nov 2019 7:00 am GNW Factsheet Curetis (0RDD) Curetis Provides Business Update for the First Nine Months of 2019
30 Oct 2019 9:00 am GNW Factsheet Curetis (0RDD) Curetis To Attend Key Conferences in the Fourth Quarter of 2019
28 Oct 2019 6:46 am GNW Factsheet Curetis (0RDD) Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test
18 Sep 2019 6:53 am GNW Factsheet Curetis (0RDD) Curetis Reports Financial Results for the First Six Months of 2019
16 Sep 2019 6:46 am GNW Factsheet Curetis (0RDD) Curetis Group Subsidiary Ares Genetics Signs R&D and Option Agreement with Leading Global IVD Corporation
04 Sep 2019 7:24 am GNW Factsheet Curetis (0RDD) Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses
12 Aug 2019 6:59 am GNW Factsheet Curetis (0RDD) Curetis Retains H.C. Wainwright & Co. as Strategic Advisor
08 Aug 2019 6:59 am GNW Factsheet Curetis (0RDD) Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing
01 Aug 2019 6:58 am GNW Factsheet Curetis (0RDD) Curetis Elects Share Settlement for Excess Entitlement Under First Tranche of Yorkville Convertible Notes
30 Jul 2019 7:01 am GNW Factsheet Curetis (0RDD) Curetis and AKO MED Ink Distribution Agreement Covering Four Countries in CEE Region
25 Jul 2019 7:00 am GNW Factsheet Curetis (0RDD) Curetis to Present at Solebury Trout European Biotech Investor Day in NYC
23 Jul 2019 6:51 am GNW Factsheet Curetis (0RDD) Curetis Files for U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens
04 Jul 2019 7:02 am GNW Factsheet Curetis (0RDD) Curetis Group Company Ares Genetics is Granted Key European Patent on Genetic Resistance Testing
02 Jul 2019 7:00 am GNW Factsheet Curetis (0RDD) Curetis To Attend Key Conferences in the Third Quarter of 2019
28 Jun 2019 6:59 am GNW Factsheet Curetis (0RDD) Curetis Reports Results of the Annual General Meeting Held on June 27, 2019
04 Jun 2019 7:11 am GNW Factsheet Curetis (0RDD) New Data on Curetis’ Unyvero LRT Panel for Pneumonia to be Presented at ASM Microbe 2019
23 May 2019 7:00 am GNW Factsheet Curetis (0RDD) Curetis Reports Positive Results from Clinical Validation Study for U.S. FDA 510(k) Submission of Unyvero LRT for BAL Samples
21 May 2019 5:55 am GNW Factsheet Curetis (0RDD) Curetis to Receive Additional EUR 6.5 Million Financing from EIB and Yorkville
17 May 2019 6:00 am GNW Factsheet Curetis (0RDD) Curetis Announces Financial Results for the First Three Months of 2019
15 May 2019 1:00 pm GNW Factsheet Curetis (0RDD) Curetis to Hold Annual General Shareholders’ Meeting on June 27, 2019
12 Apr 2019 7:00 am GNW Factsheet Curetis (0RDD) Press release: Curetis’ Subsidiary Ares Genetics Introduces NGS Services for Pharma and Public Health Sector at Upcoming ECCMID 2019
11 Apr 2019 7:01 am GNW Factsheet Curetis (0RDD) Curetis Publishes Full-Year 2018 Financial Results and Updated Guidance for 2019
05 Apr 2019 7:59 am GNW Factsheet Curetis (0RDD) Curetis to Publish its Full-Year 2018 Financial Results on April 11, 2019
04 Apr 2019 7:00 am GNW Factsheet Curetis (0RDD) Curetis: Study Data Presented at ECCMID 2019 Confirm Clinical Benefits of Unyvero Platform
02 Apr 2019 7:04 am GNW Factsheet Curetis (0RDD) Curetis Introduces Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance
01 Apr 2019 1:59 pm GNW Factsheet Curetis (0RDD) Curetis To Attend Key Conferences in the Second Quarter of 2019
26 Mar 2019 7:00 am GNW Factsheet Curetis (0RDD) Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero
18 Feb 2019 9:05 pm GNW Factsheet Curetis (0RDD) Curetis’ Subsidiary Ares Genetics and QIAGEN Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance
04 Feb 2019 6:59 am GNW Factsheet Curetis (0RDD) Curetis’ Partner Beijing Clear Biotech Submits Filing for Unyvero Approval in China
30 Jan 2019 6:50 am GNW Factsheet Curetis (0RDD) Curetis’ Unyvero Application Cartridges Receive Regulatory Approvals in Malaysia and Thailand
08 Jan 2019 7:00 am GNW Factsheet Curetis (0RDD) Curetis’ Subsidiary Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test
18 Dec 2018 7:00 am GNW Factsheet Curetis (0RDD) Curetis’ Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance
13 Dec 2018 8:04 am GNW Factsheet Curetis (0RDD) Curetis Sharpens Focus on Near-Term Strategic Value Drivers
23 Nov 2018 6:44 am GNW Factsheet Curetis (0RDD) Curetis Announces Financial Results for the First Nine Months of 2018
  6:08 am GNW Factsheet Curetis (0RDD) Curetis Accelerates 510(k) Submission Preparation for Unyvero LRT in BAL Specimen Based on Positive FDA Feedback
07 Nov 2018 5:50 pm GNW Factsheet Curetis (0RDD) Curetis raises €8.9 million through private placements
02 Nov 2018 7:17 am GNW Factsheet Curetis (0RDD) Curetis launches privately placed capital increase to raise up to €18.4 million
11 Oct 2018 7:59 am GNW Factsheet Curetis (0RDD) Curetis, Beijing Clear Biotech Expand Strategic Collaboration for Unyvero in Greater China
02 Oct 2018 7:15 am GNW Factsheet Curetis (0RDD) Curetis secures financing facility of up to EUR 20 million through the issuance of convertible notes
28 Sep 2018 9:11 am GNW Factsheet Curetis (0RDD) Curetis Publishes Interim Report for the First Half-Year 2018
17 Sep 2018 6:00 am GNW Factsheet Curetis (0RDD) Curetis To Attend Key Investor and Scientific Conferences In The Fourth Quarter 2018


Company Announcements Archive »

 
Headlines
Top categories

10-Jul-2020 09:00 AM

Market Movers - Top risers and fallers at 09:00

FTSE 100 Scottish Mortgage Investment Trust 915.75 +1.75% Homeserve 1269.00 +1.44% Sse ...

Company finder

a d v e r t i s e m e n t